Skull injection shows promise for severe stroke patients
Disease control
Not yet recruiting
This early-phase study tests a new drug called RK-4 for people with a severe type of stroke (large hemispheric infarction) who cannot have standard treatment. The drug is injected directly into the skull bone marrow once daily for three days. The main goals are to check if the dr…
Phase: PHASE1, PHASE2 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC